Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 276-594-2 | CAS number: 72361-35-4
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.53 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 75
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 264.32 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- NOAECcorr = NOAELoral*(1/0.38 m³/kg bw/day)*(ABSoral-rat/ABSinh-human)*(6.7 m³ (8h)/10 m³ (8h)) = 300 mg/kg bw/day*(1/0.38 m³/kg bw/day)*(0.5/1)*0.67 = 264.32 mg/m³. It is assumed that dermal absorption rate is 50% of that of inhalation absorption. ABSoral-rat=oral absorption rate in rats, ABSinh-human=inhalation absorption rate in humans. Adverse effects were seen in the available subacute oral study at the highest concentration/dose level tested. Therefore, the NOAEL (300 mg/kg bw/day) from this subacute oral toxicity study was the most sensitive effect level and was selected for DNEL derivation by means of route-to-route extrapolation.
- AF for dose response relationship:
- 1
- Justification:
- DNEL is based on a NOAEL
- AF for differences in duration of exposure:
- 6
- Justification:
- DNEL is based on a 28-d study
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- AF not used for inhalation route
- AF for other interspecies differences:
- 2.5
- Justification:
- Default AF
- AF for intraspecies differences:
- 5
- Justification:
- Default AF for workers
- AF for the quality of the whole database:
- 1
- Justification:
- The selected study is the moste adequate and reliable study.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainities
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 5 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 500 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- NOAELcorr = NOAELoral*(ABSoral-rat/ABSdermal-human) = (300 mg/kg bw/day)*(0.5/0.1) = 1500 mg/kg bw/day. It is assumed that the dermal absorption rate is 10% (20% of that of the oral absorption) based on the available data and physico-chemical properties of the PFAE aromatic category members (high MW, very high LogPow, very low water solubility)according to ECHA CSA Guidance Chapter R.7c. ABSoral-rat=oral absorption rate in rats, ABSdermal-human=dermal absorption rate in humans.
- AF for dose response relationship:
- 1
- Justification:
- DNEL is based on a NOAEL
- AF for differences in duration of exposure:
- 6
- Justification:
- DNEL is based on a 28-d study
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default AF for rats
- AF for other interspecies differences:
- 2.5
- Justification:
- Default AF
- AF for intraspecies differences:
- 5
- Justification:
- Default AF for workers
- AF for the quality of the whole database:
- 1
- Justification:
- The selected study is the most adequate and reliable study
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainities
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
The long-term DNELs are based on a 28-day oral feeding study performed in Sprague Dawley rats with 1,2,4-Benzenetricarboxylic acid, decyl octyl ester (CAS 90218-76-1) as a Read Across substance. The NOAEL in this study was found to be 300 mg/kg bw/day based on systemic effects (reduced body weight, males; hair loss, females; increased leucocytes, females and (reversible) effects on adrenals and liver) at the highest dose of 1000 mg/kg bw/day. In another 28-day oral feeding study performed withTris(2-ethylhexyl) benzene-1,2,4-tricarboxylate (CAS No. 3319-31-1), a surrogate substance, no adverse effects were observed up to the highest dose of 1000 mg/kg bw/day. The long-term systemic DNELs were derived based on the most sensitive NOAEL being 300 mg/kg bw/day.
As the DNELs were derived for the whole category, no adaption regarding the molecular weight was done. However, the Read Across substance tested in the respective study is the category member with the lowest molecular weight und thus, the derived DNELs can be seen as the worst case calculation with regard to the other category members.
The assessment factors were chosen according to ECHA Guidance document R.8 (Characterisation of dose [concentration]-response for human health, May 2008.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.87 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 150
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 130.5 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- NOAECcorr = NOAELoral*(1/1.15 m³/kg bw/day)*(ABSoral-rat/ABSinh-human) = 300 mg/kg bw/day*(1/1.15 m³/kg bw/day)*(0.5/1) = 130.5 mg/m³. It is assumed that dermal absorption rate is 50% of that of inhalation absorption. ABSoral-rat=oral absorption rate in rats, ABSinh-human=inhalation absorption rate in humans. No adverse effects were seen in the available subacute inhalation study and the subacute and subchronic oral studies up to and including the highest concentration/dose level tested. Therefore, the lowest dose descriptor from the study with the longest duration, i.e. the NOAEL from the subchronic oral toxicity study, was selected for DNEL derivation by means of route-to-route extrapolation.
- AF for dose response relationship:
- 1
- Justification:
- DNEL is basedon a NOAEL
- AF for differences in duration of exposure:
- 6
- Justification:
- DNEL is based on a 28-day study
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- AF not used for inhalation route
- AF for other interspecies differences:
- 2.5
- Justification:
- Default AF
- AF for intraspecies differences:
- 10
- Justification:
- Default AF for general population
- AF for the quality of the whole database:
- 1
- Justification:
- The selected study is the most adequate and reliable study.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.5 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 500 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- NOAELcorr = NOAELoral*(ABSoral-rat/ABSdermal-human) = (300 mg/kg bw/day)*(0.5/0.1) = 1500 mg/kg bw/day. It is assumed that the dermal absorption rate is 10% (20% of that of the oral absorption) based on the available data and physico-chemical properties of the PFAE aromatic category members (high MW, very high LogPow, very low water solubility)according to ECHA CSA Guidance Chapter R.7c. ABSoral-rat=oral absorption rate in rats, ABSdermal-human=dermal absorption rate in humans.
- AF for dose response relationship:
- 1
- Justification:
- DNEL is based on a NOAEL
- AF for differences in duration of exposure:
- 6
- Justification:
- DNEL is based on a 28-d study
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default AF for rats
- AF for other interspecies differences:
- 2.5
- Justification:
- Default AF
- AF for intraspecies differences:
- 10
- Justification:
- Default AF for general population
- AF for the quality of the whole database:
- 1
- Justification:
- The selected study is the moste adequate and reliable study.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.5 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 300 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- No route to route extrapolation is required.
- AF for dose response relationship:
- 1
- Justification:
- DNEL is based on a NOAEL
- AF for differences in duration of exposure:
- 6
- Justification:
- DNEL is based on a 28-day study
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default AF for rats
- AF for other interspecies differences:
- 2.5
- Justification:
- Default AF
- AF for intraspecies differences:
- 10
- Justification:
- Default AF for general population
- AF for the quality of the whole database:
- 1
- Justification:
- The selected study is the most adequate and reliable study.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
The long-term DNELs are based on a 28-day oral feeding study performed in Sprague Dawley rats with 1,2,4-Benzenetricarboxylic acid, decyl octyl ester (CAS 90218-76-1) as a Read Across substance. The NOAEL in this study was found to be 300 mg/kg bw/day based on systemic effects (reduced body weight, males; hair loss, females; increased leucocytes, females and (reversible) effects on adrenals and liver) at the highest dose of 1000 mg/kg bw/day. In another 28-day oral feeding study performed withTris(2-ethylhexyl) benzene-1,2,4-tricarboxylate (CAS No. 3319-31-1), a surrogate substance, no adverse effects were observed up to the highest dose of 1000 mg/kg bw/day. The long-term systemic DNELs were derived based on the most sensitive NOAEL being 300 mg/kg bw/day.
As the DNELs were derived for the whole category, no adaption regarding the molecular weight was done. However, the Read Across substance tested in the respective study is the category member with the lowest molecular weight und thus, the derived DNELs can be seen as the worst case calculation with regard to the other category members.
The assessment factors were chosen according to ECHA Guidance document R.8 (Characterisation of dose [concentration]-response for human health, May 2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
